Asian Phytoceuticals PCL (BKK:APCO)

Asian Phytoceuticals PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72.03	62.37	125.63	82.15	98.59	100.2
Short-Term Investments	22.16	76.37	102.01	61.25	32.23	0.53
Trading Asset Securities	251.33	212.92	23.54	35.75	36.09	71.3
Cash & Short-Term Investments	345.52	351.66	251.19	179.15	166.92	172.04
Cash Growth	33.79%	40.00%	40.21%	7.33%	-2.98%	-64.14%
Accounts Receivable	0.89	3.38	0.89	0.98	0.54	1.75
Other Receivables	5.29	2.11	3.34	3.23	2.74	3.54
Receivables	6.18	5.49	4.22	4.21	3.29	5.29
Inventory	59.97	57.03	44.27	52.88	59.94	62.33
Prepaid Expenses	1.26	1.14	0.9	0.92	0.67	0.71
Other Current Assets	0.29	0.2	0.23	0.35	0.3	0.35
Total Current Assets	413.22	415.53	300.82	237.51	231.11	240.72
Property, Plant & Equipment	65.54	66.44	82.34	64.02	91.21	113.39
Long-Term Investments	148.61	136.11	303.86	365.01	346.73	331.93
Other Intangible Assets	0.71	0.61	0.79	0.24	0.36	0.5
Long-Term Deferred Tax Assets	11.38	11.18	10.75	7.11	5.05	4.16
Other Long-Term Assets	6.16	6.14	6.17	6.25	6.07	6.08
Total Assets	645.62	636.02	704.72	680.15	680.53	696.78
Accounts Payable	1.15	0.77	1.2	0.64	1.99	0.63
Accrued Expenses	16.14	16.08	16.47	14.46	14.07	16.87
Current Portion of Leases	14.59	13.2	13.45	12.2	18.74	18.42
Current Income Taxes Payable	7.27	5.2	10.77	12.7	9.64	9.01
Current Unearned Revenue	0.26	0.29	0.26	0.31	0.32	0.26
Other Current Liabilities	3.34	3.12	4.05	4.78	2.99	3.68
Total Current Liabilities	42.75	38.64	46.2	45.1	47.75	48.87
Long-Term Leases	9.93	10.91	22.22	1.62	15.49	31.59
Other Long-Term Liabilities	4.04	4.04	4.04	4.04	5.01	3.4
Total Liabilities	77.6	76.3	92.34	69.64	85.54	101.31
Common Stock	300	300	300	300	300	300
Additional Paid-In Capital	166.94	166.94	166.94	166.94	166.94	166.94
Retained Earnings	121.57	109.06	161.63	146.3	126.75	125.26
Comprehensive Income & Other	-23.43	-19.18	-18.88	-5.27	1.3	3.26
Total Common Equity	565.08	556.82	609.7	607.98	594.99	595.46
Minority Interest	2.95	2.89	2.69	2.53	-	-
Shareholders' Equity	568.03	559.72	612.39	610.51	594.99	595.46
Total Liabilities & Equity	645.62	636.02	704.72	680.15	680.53	696.78
Total Debt	24.52	24.11	35.67	13.82	34.23	50.01
Net Cash (Debt)	321.01	327.56	215.52	165.33	132.69	122.02
Net Cash Growth	42.03%	51.99%	30.36%	24.60%	8.74%	-74.57%
Net Cash Per Share	0.52	0.54	0.36	0.28	0.22	0.20
Filing Date Shares Outstanding	600	600	600	600	600	600
Total Common Shares Outstanding	600	600	600	600	600	600
Working Capital	370.47	376.88	254.62	192.42	183.36	191.84
Book Value Per Share	0.94	0.93	1.02	1.01	0.99	0.99
Tangible Book Value	564.37	556.22	608.91	607.74	594.64	594.96
Tangible Book Value Per Share	0.94	0.93	1.01	1.01	0.99	0.99
Land	-	8.29	8.29	8.29	8.29	8.29
Buildings	-	90.24	93.72	91.07	91.04	94.77
Machinery	-	82.06	82.71	82.49	82.74	86.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.